Diffusion Pharmaceuticals Inc

NASDAQ:DFFN  
0.34
-0.03 (-8.37%)
Earnings Announcements

Diffusion Pharmaceuticals Reports Third Quarter Financial Results

Published: 11/10/2021 12:12 GMT
Diffusion Pharmaceuticals Inc (DFFN) - Diffusion Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update.
Diffusion Pharmaceuticals Inc - Qtrly Net Loss per Share $0.12.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.